Green Park Collaborative – USA

A New Partnership for Effectiveness and Innovation in Health Care

The Center for Medical Technology Policy is pleased to announce the formation of the Green Park Collaborative – USA (GPC-USA), a new multi-stakeholder forum that will develop condition-specific study design recommendations to guide the generation of evidence needed to inform coverage and payment decisions in the United States. The GPC-USA will provide a neutral forum within which payers, life sciences companies, patients, clinicians, researchers, regulators and other stakeholders can engage in dialogue regarding methodological standards for studies intended to demonstrate real world effectiveness and value. In 2013, the work of the GPC-USA will focus on methodological standards for clinical development and market access in oncology and diabetes. The  GPC-USA Inaugural Meeting was held May 1 in Baltimore, Maryland.  Presentations are available here.

For membership information, contact Corinne Warren and view Green Park Collaborative - USA Overview (pdf) (263.3 kB) .

Green Park Collaborative International

The work of the GPC-USA is informed by CMTP’s experience managing GPC-International, a partnership between Health Technology Assessment International (HTAi) and CMTP. GPC-I recently completed a pilot project that assessed the feasibility of developing global guidance for the life sciences industry on the design of clinical studies to meet the needs of Health Technology Assessment (HTA) and coverage bodies. The GPC-I pilot project on Alzheimer’s Disease will be completed in the Spring of 2013, and the final pilot EGD and evaluation report will be made public at that time. Those wishing to learn more about GPC-I should contact Corinne Warren.